Why do immune cells that are supposed to eliminate viruses suddenly turn against our own body? There are instances where ...
News-Medical.Net on MSN
Mitochondria and lysosomes work together to control regulatory T cell activation
Metabolism guides the activation states of regulatory T cells, the immune cells that prevent inappropriate activation of the ...
SITC abstracts highlight updated immunogenicity results from the Phase 2 AMPLIFY-7P trial of ELI-002 7P and preclinical data on the use of ...
HCW Biologics debuted the results from its preclinical study of HCW11-018b, the Company’s lead T-cell engager product candidate, that highlights the uniqueness and advantages of its second-generation ...
This article is based on a poster originally authored by Weiping Sun, Xing Zhang, Zhaolu Yan, Chen Yu, Spencer Chiang, and Tianfu Zhang. Immunotherapy is an advanced and widely used treatment due to ...
Even for a newly minted Nobel laureate, downtime is hard to find. | Even for a newly minted Nobel laureate, downtime is hard to find. Just a few weeks after winning the 2025 Nobel Prize in Physiology ...
Enara Bio, a biopharmaceutical company pioneering the discovery of novel Dark Antigens (R) and the development of bispecific T cell engagers for solid tumors, will unveil its newly discovered ...
A novel nanoparticle system combines sonodynamic therapy and ferroptosis to effectively target hepatocellular carcinoma and ...
To make the therapy safer and more adaptable, UChicago researchers developed a new “split” system called GA1CAR. This uses ...
The two-drug regimen dolutegravir/lamivudine is as effective as the three-drug regimen dolutegravir plus tenofovir ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback